pentoxifylline has been researched along with Infant, Premature, Diseases in 12 studies
Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pentoxifylline (PTX) is a candidate for adjunct immunomodulatory therapy in preterm infants with late-onset sepsis (LOS) and necrotizing enterocolitis (NEC), but pharmacokinetic data in this population are extremely limited." | 9.30 | Effects of maturation and size on population pharmacokinetics of pentoxifylline and its metabolites in very preterm infants with suspected late-onset sepsis or necrotizing enterocolitis: a pilot study incorporating clinical outcomes. ( Batty, KT; Doherty, DA; Hibbert, J; Manning, L; Page-Sharp, M; Patole, S; Salman, S; Simmer, K; Strunk, T, 2019) |
| "To evaluate the influence of the methylxanthine derivative, pentoxifylline, on plasma levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1, and IL-6 in prematurely delivered infants with generalized bacterial infections and to assess the effect of this immunomodulating drug on the clinical outcome in newborns with sepsis." | 9.09 | Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. ( Helwich, E; Kowalczyk, D; Ksycínski, W; Lauterbach, R; Pawlik, D; Zembala, M, 1999) |
| "Pentoxifylline (Trental, 5 mg/kg/h for 6 h) was administered to 17 premature infants with sepsis, on 3 successive days." | 9.07 | Pentoxifylline treatment of sepsis of premature infants: preliminary clinical observations. ( Cholewa, B; Lauterbach, R; Pawlik, D; Tomaszczyk, B, 1994) |
| "Pentoxifylline (PTX) is a candidate adjuvant medication for the treatment of sepsis and necrotizing enterocolitis in preterm infants." | 7.96 | Intravenous pentoxifylline is well tolerated in critically ill preterm infants with sepsis or necrotizing enterocolitis. ( Berger, A; Kempf, K; Schüller, SS; Strunk, T; Unterasinger, L, 2020) |
| " Pentoxifylline (PTX) is a candidate for adjunct immunomodulatory therapy in preterm infants with late-onset sepsis (LOS) and necrotizing enterocolitis (NEC), but pharmacokinetic data in this population are extremely limited." | 5.30 | Effects of maturation and size on population pharmacokinetics of pentoxifylline and its metabolites in very preterm infants with suspected late-onset sepsis or necrotizing enterocolitis: a pilot study incorporating clinical outcomes. ( Batty, KT; Doherty, DA; Hibbert, J; Manning, L; Page-Sharp, M; Patole, S; Salman, S; Simmer, K; Strunk, T, 2019) |
| "To evaluate the efficacy and safety of nebulized pentoxifylline for reducing the duration of oxygen supplementation in extremely preterm neonates at high risk of bronchopulmonary dysplasia (BPD)." | 5.20 | Nebulized pentoxifylline for reducing the duration of oxygen supplementation in extremely preterm neonates. ( Deshmukh, M; Doherty, DA; Nathan, EA; Patole, SK; Schulzke, SM, 2015) |
| "To evaluate the influence of the methylxanthine derivative, pentoxifylline, on plasma levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1, and IL-6 in prematurely delivered infants with generalized bacterial infections and to assess the effect of this immunomodulating drug on the clinical outcome in newborns with sepsis." | 5.09 | Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. ( Helwich, E; Kowalczyk, D; Ksycínski, W; Lauterbach, R; Pawlik, D; Zembala, M, 1999) |
| "Pentoxifylline (Trental, 5 mg/kg/h for 6 h) was administered to 17 premature infants with sepsis, on 3 successive days." | 5.07 | Pentoxifylline treatment of sepsis of premature infants: preliminary clinical observations. ( Cholewa, B; Lauterbach, R; Pawlik, D; Tomaszczyk, B, 1994) |
| "Pentoxifylline (PTX) is a candidate adjuvant medication for the treatment of sepsis and necrotizing enterocolitis in preterm infants." | 3.96 | Intravenous pentoxifylline is well tolerated in critically ill preterm infants with sepsis or necrotizing enterocolitis. ( Berger, A; Kempf, K; Schüller, SS; Strunk, T; Unterasinger, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Schüller, SS | 1 |
| Kempf, K | 1 |
| Unterasinger, L | 1 |
| Strunk, T | 2 |
| Berger, A | 1 |
| Salman, S | 1 |
| Hibbert, J | 1 |
| Page-Sharp, M | 1 |
| Manning, L | 1 |
| Simmer, K | 1 |
| Doherty, DA | 2 |
| Patole, S | 1 |
| Batty, KT | 1 |
| Schulzke, SM | 2 |
| Kaempfen, S | 1 |
| Patole, SK | 2 |
| Deshmukh, M | 1 |
| Nathan, EA | 1 |
| Harpavat, S | 1 |
| Pammi, M | 1 |
| Gilger, M | 1 |
| Mohan, PV | 1 |
| Tarnow-Mordi, W | 1 |
| Stenson, B | 1 |
| Brocklehurst, P | 1 |
| Haque, K | 1 |
| Cavendish, V | 1 |
| Cust, A | 1 |
| Lauterbach, R | 5 |
| Pawlik, D | 2 |
| Tomaszczyk, B | 1 |
| Cholewa, B | 1 |
| Zembala, M | 2 |
| Zimmerman, JJ | 1 |
| Kowalczyk, D | 1 |
| Ksycínski, W | 1 |
| Helwich, E | 1 |
| Szymura-Oleksiak, J | 1 |
4 reviews available for pentoxifylline and Infant, Premature, Diseases
| Article | Year |
|---|---|
Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infants.
Topics: Bronchopulmonary Dysplasia; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Pre | 2014 |
Novel treatments for NEC: keeping IBD in mind.
Topics: Enterocolitis, Necrotizing; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Infant, Pre | 2012 |
Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Brain Diseases; Chronic Disease; Cytokines; Humans | 2004 |
Appraising the potential of pentoxifylline in septic premies.
Topics: Critical Care; Cytokines; Drug Administration Schedule; Free Radical Scavengers; Humans; Infant, New | 1999 |
6 trials available for pentoxifylline and Infant, Premature, Diseases
| Article | Year |
|---|---|
Effects of maturation and size on population pharmacokinetics of pentoxifylline and its metabolites in very preterm infants with suspected late-onset sepsis or necrotizing enterocolitis: a pilot study incorporating clinical outcomes.
Topics: Administration, Intravenous; Body Weight; Drug Therapy, Combination; Enterocolitis, Necrotizing; Fem | 2019 |
Nebulized pentoxifylline for reducing the duration of oxygen supplementation in extremely preterm neonates.
Topics: Bronchopulmonary Dysplasia; Continuous Positive Airway Pressure; Double-Blind Method; Female; Humans | 2015 |
Pentoxifylline treatment of sepsis of premature infants: preliminary clinical observations.
Topics: Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, D | 1994 |
Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis.
Topics: Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Pentoxifylline; Prospective | 1996 |
Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.
Topics: Adjuvants, Immunologic; Double-Blind Method; Drug Administration Schedule; Female; Free Radical Scav | 1999 |
Nebulized pentoxifylline in successful treatment of five premature neonates with bronchopulmonary dysplasia.
Topics: Administration, Inhalation; Bronchopulmonary Dysplasia; Drug Administration Schedule; Enzyme Inhibit | 1999 |
2 other studies available for pentoxifylline and Infant, Premature, Diseases
| Article | Year |
|---|---|
Intravenous pentoxifylline is well tolerated in critically ill preterm infants with sepsis or necrotizing enterocolitis.
Topics: Critical Illness; Drug Administration Schedule; Enterocolitis, Necrotizing; Female; Humans; Infant, | 2020 |
Pentoxifylline treatment of persistent pulmonary hypertension of newborn.
Topics: Chronic Disease; Humans; Hypertension, Pulmonary; Infant, Newborn; Infant, Premature, Diseases; Pent | 1993 |